SMIadviser.org will not be accessible after 11:59pm ET on July 8, 2024. Thank you for your support over the past six years!

An APA and SAMHSA Initiative

Clinicians
Clinicians Home Consult Request Knowledge Base Education Catalog Centers Of Excellence
Individuals & Families
Guidance Knowledge Base Person-First Language
Our Tools
SMI Adviser App My Mental Health Crisis Plan Clozapine Dose Planner LAI Conversion Tool LAI Explorer
About Us
Calendar
Contact

Search for:

∕
Knowledge Base (Clinicians)
∕
Co-morbid Medical Conditions

Tag: Co-morbid Medical Conditions

Knowledge Base (Clinicians)

59 result(s) found.

How should people with schizophrenia be screened for heart disease and diabetes?
How can people with serious mental illnesses better manage their chronic medical conditions and improve diet and physical activity?
Position Statement 13: Integration of Mental and General Health Care
Management of physical health conditions in adults with severe mental disorders
Integrated Care
Should I be concerned if eosinophils are low or high with clozapine or there is eosinophilia?
What about anemia in people with serious mental illness, and should I be concerned about ordering blood tests?
Are there any contraindications or reasons a patient cannot be considered for clozapine? Can a patient with myocarditis or severe neutropenia be rechallenged and take clozapine again?
What is Benign Ethnic Neutropenia and does it relate to low clozapine white counts?
What should primary care providers know how to do if they are working in mental health setting?
How does opioid use disorder increase the risk of contracting Hepatitis C and HIV?
Is it possible to receive primary care inside an opiate treatment program?
How do you optimize the clinical management of persons opioid use disorders (OUD) and co-occurring psychiatric disorders who are actively using opioids and are experiencing significant pain?
How do primary care providers and mental health experts feel about opioid and benzodiazepines co-prescribing?
What is known about psychiatric disorders in people with a mitochondrial myopathy?
What are the issues regarding starting clozapine in a patient with structural heart disease, such as cardiomyopathy or cardiac valve disease?
Substance Use Disorders
Are community mental health providers screening for metabolic problems in their patients with serious mental illnesses?
First and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update
Interventions for Adult Offenders With Serious Mental Illness
Training Projects/Weight Management and Well-being
Illness Management and Recovery Evidence-Based Practices (EBP) Kit
Integrated Treatment for Co-Occurring Disorders Evidence-Based Practices (EBP) Kit
Preventing Suicide: A Technical Package of Policy, Programs, and Practices
Promoting Wellness for People in Mental Health Recovery: A Step by Step Guide to Planning and Conducting a Success Health Fair
Whole Health Action Management (WHAM) Peer Support Training
What is there to know about PReP pre-exposure prophylaxis for prevention of HIV in patients with serious mental illness?
What about asymptomatic increases in liver function tests or transaminases while taking psychotropic medication?
What if hepatitis or liver cirrhosis develops in patients taking anti-psychotic medication?
What is the best way to assess cognitive functioning in individuals with serious mental illness (SMI) without using a long battery of neurocognitive tests?
Integrated Care for Older Adults with Serious Mental Illness and Medical Comorbidity: Evidence Based Models and Future Research Directions
Diabetes screening among underserved adults with severe mental illness who take antipsychotic medications
A Nursing Approach to Self-Management Education for Individuals With Mental Illness and Diabetes
Training Peer Educators to Promote Self-Management Skills in People with Serious Mental Illness (SMI) and Diabetes (DM) in a Primary Health Care Setting
Integrating Physical Health Care in Behavioral Health Agencies in Rural Pennsylvania
The Psychiatrist’s Guide to Population Management of Diabetes – eCourse
Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls.
What should be done if hepatic liver function tests are increased with clozapine treatment?
Are there concerns regarding urinary retention and antidepressant medications?
Can peer support for older adults with psychiatric disorders help to mitigate the increases in serious mental health problems for this age group?
What about prescribing anticholinergic medications such as benztropine to patients taking antipsychotic medications?
Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition)
Ask The Doctor: Reversing Health Disparities In People With Serious Mental Illness
Center of Excellence for Integrated Health Solutions
Health Disparities Among People With Serious Mental Illness
What are approaches for treating or managing anxiety in patients with schizophrenia who are taking clozapine?
What should mental health providers know about coronavirus (COVID-19)?
Can facilities bill for peer specialist services addressing physical health care?
How can care managers use motivational interviewing to help promote positive health behavior change in their patients with serious mental illness?
What is Assertive Community Treatment (ACT) for people with severe mental illness?
Implementation Guide: Serious Mental Illness (SMI) and Co-Occurring Disorders (COD)
Implementation Guide: Integrated screening and longitudinal, strength-based assessment for individuals with serious mental illness (SMI) and co-occurring substance use
Implementation Guide: Stage-Matched Interventions for Individuals with Serious Mental Illness (SMI) and Co-Occurring Substance Use
Implementation Guide: Skill-Building Interventions for Individuals with Serious Mental Illness (SMI) and Co-Occurring Substance Use Disorders
Implementation Guide: Integrated Medications for Addiction Treatment (MAT) for Opioid Use Disorder (OUD) in a Serious Mental Illness (SMI) Service Setting
What are some of the key elements in clinics that provide medical services to individuals with serious mental illnesses in community mental health settings?
How can I provide reliable education about enhancing immunity to a variety of illnesses?
How can I provide reliable education on diabetes self-management in both English and Spanish?
Clozapine & LAI Virtual Forum – September 2022 (Video) – Appropriate use of weight loss medication with clozapine with a focus on GLP-1 agonists

Join our #MissionForBetter now

Sign up for our newsletter. We’ll let you know about new resources, education, and more.

Administered by

Funded by

About SMI Adviser

Mission Statement

Our mission is to advance the use of a person-centered approach to care that ensures people who have SMI find the treatment and support they need.

For clinicians, we offer access to education, data, and consultations so you can make evidence-based treatment decisions.

For patients, families, friends, people who have questions, or people who care for someone with SMI, we offer access to resources and answers from a national network of experts.

Grant Statement

Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.

Terms & Privacy
Copyright

Sitemap

Clinicians
Individuals & Families
About
Contact

SMI Adviser is committed to ensuring accessibility of its website to people with disabilities. If you have trouble accessing any of the website's resources, please call us at 202-559-3900 for assistance.

Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.

© 2024 American Psychiatric Association. All rights reserved.